Epithelial ovarian cancer in Southern Africa
نویسندگان
چکیده
منابع مشابه
epigenetic brca2 gene in epithelial ovarian cancer
background ovarian cancer is the most common fatal gynecologic malignancy in women. the brca2 gene has a role in regulation of cell cycle during proliferation, differentiation and dna repair. changes in the methylation of brca2 may be an effective mechanism for ovarian cancer. objectives the aim of the present study was to evaluate the association between ovarian cancer and methylation status o...
متن کاملserum her2 level in epithelial ovarian cancer
introduction : the proto-oncogene her2 plays a key role in the control of cellular proliferation. its overexpression has been reported to be associated with a poor prognosis in cancer, particularly in breast cancer. materials and methods : in the present study, serum her2 levels were investigated in patients diagnosed with epithelial ovarian cancer. serum her2 levels were detected by an elisa c...
متن کاملReview: Cervical cancer in Southern Africa: The challenges Cervical cancer in Southern Africa: The challenges
Introduction Cervical cancer remains the second most common cancer among women worldwide and the most common cancer amongst black African women in South Africa. Annually there are 500 000 cases of cervical cancer worldwide, of which the mortality is about 50%. This is largely due to presentation at a late stage. Lack of availability of treatment facilities may be another factor contributing to ...
متن کاملFailure to Demonstrate the Role of High Risk Human Papilloma Virus in Epithelial Ovarian Cancer
Background and Aims: Ovarian cancer is one of most common causes of cancer related women's mortalities. Human papilloma virus is a known factor concerning cervical cancer but its role in causing ovarian cancer is not yet verified. A few studies also identified HPV DNA in ovarian carcinoma tissues. However, some studies did not detect HPV DNA in ovarian carcinoma tissues. In this articl...
متن کاملIrinotecan in epithelial ovarian cancer.
Ovarian cancer, the second most common gynecologic malignancy, accounts for approximately 14,000 deaths annually in the United States. Disease relapse after primary treatment, which consists mainly of surgery followed by platinum-based therapy, occurs in more than 60% of ovarian cancer patients overall, and in more than 80% of those diagnosed initially with advanced-stage disease. Responses to ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Southern African Journal of Gynaecological Oncology
سال: 2009
ISSN: 2074-2835,2220-105X
DOI: 10.1080/20742835.2009.11441130